Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.

Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.